Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 9/19/2008 First Published: 8/13/2006


1.		Phase III Randomized Study of Zoledronate, Vitamin D, and Calcium With or Without Strontium Chloride Sr 89 or Samarium Sm 153 Lexidronam Pentasodium in Preventing or Delaying Skeletal-Related Events in Patients With Bone Metastases Secondary to Prostate, Lung, or Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				NCI				RTOG-0517 RTOG 0517, RTOG-0517, NCT00365105


2.		A Study of Actonel for the Prevention of Bone Loss

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				ID03-0124 NCT00452439

Last Modified: 10/2/2007 First Published: 12/21/2006


3.		Phase II Pilot Study of Vitamin D Deficiency and Myalgias and/or Arthralgias in Postmenopausal Women Receiving Adjuvant Letrozole for Stage I-III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Natural history/Epidemiology, Supportive care, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				UWCC-6346 NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715


4.		Bone Health in Gynecologic Cancers-Does FOSAVANCE Help?

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Approved-not yet active				18 and over				Other				H06-03974 9427-UO146-93C, NCT00593580


5.		Effect of Vitamin D and Calcium on Genes in the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				48 to 72				Other				RUH IRB # PHO-0554 NCT00298545


6.		Vitamin D for Chemoprevention

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				30 to 80				Other				07-342 NCT00585637


7.		High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				Postmenopausal				Other				05-0498 NCT00263185


8.		Development of Vitamin D as a Therapy for Breast Cancer - Phase II

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				SU-03052008-1030 98671, BRSNSTU0026, NCT00656019, NCT00656019

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute